BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 17496537)

  • 21. Computer analysis of cadaver kidney allocation procedures.
    Wujciak T; Opelz G
    Transplantation; 1993 Mar; 55(3):516-21. PubMed ID: 8456470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omit HLA matching to attain shorter cold ischemic time?
    Aswad S; Mann SL; Khetan U; Asai P; Bogaard T; Mendez RG; Mendez R
    Transplant Proc; 1993 Dec; 25(6):3053-5. PubMed ID: 8266450
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage.
    Aydingoz SE; Takemoto SK; Pinsky BW; Salvalaggio PR; Lentine KL; Willoughby L; Hoover B; Burroughs TA; Schnitzler MA; Graff R
    Hum Immunol; 2007 Jun; 68(6):491-9. PubMed ID: 17509448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional vs. national renal sharing organizations: pros and cons.
    Bertoni E; Carmellini M; Bandini S; Tosi P; Zanazzi M; Rosati A; Pradella F; Fossombroni V; Rindi P; Rizzo G; Mattiuz P; Mosca F; Salvadori M
    Clin Transplant; 1997 Jun; 11(3):214-6. PubMed ID: 9193845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The economic implications of HLA matching in cadaveric renal transplantation.
    Schnitzler MA; Hollenbeak CS; Cohen DS; Woodward RS; Lowell JA; Singer GG; Tesi RJ; Howard TK; Mohanakumar T; Brennan DC
    N Engl J Med; 1999 Nov; 341(19):1440-6. PubMed ID: 10547408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.
    Stobbe I; van der Meer-Prins EM; de Lange P; Oudshoorn M; De Meester J; Doxiadis II; Claas FH
    Transplantation; 2000 Jul; 70(1):157-61. PubMed ID: 10919594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Important of HLA matching in cadaveric renal transplantation. A prospective one-center study.
    Moen T; Flatmark A; Jervell J; Dahl O; Halvorsen S; Solheim B; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():64-71. PubMed ID: 6815795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 32. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of corneal transplantation and human leukocyte antigen matching].
    Liu Y; Zhang R; Guan L
    Zhonghua Yan Ke Za Zhi; 1996 Sep; 32(5):369-71. PubMed ID: 9590831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
    Opelz G; Döhler B
    Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
    Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
    Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved kidney graft survival through HLA-DR-MT matching.
    Müller GA; Müller C; Wernet P
    Proc Eur Dial Transplant Assoc; 1983; 19():464-8. PubMed ID: 6348746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human leukocyte antigens DR and AB and kidney retransplantation.
    Thompson JS; Thacker LR; Krishnan G
    Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
    Tran TH; Döhler B; Heinold A; Scherer S; Ruhenstroth A; Opelz G
    Transplantation; 2011 Aug; 92(4):419-25. PubMed ID: 21743387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
    Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.